| Recent therapeutic advances and insights of recurrent glioblastoma multiforme . | |
| | |
MedLine Citation:
|
PMID: 23276952 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Despite recent therapeutic advances, most patients with glioblastoma multiforme (GBM) experience disease recurrence, with very poor prognosis. Much work still needs to done to improve the treatment efficacy. The optimal management of patients with recurrent GBM is still controversial. This article summarizes the current status of therapeutic strategies in recurrent glioblastoma patients, with an emphasis on more novel approaches and important recent progress. The clinical evidence of current treatment strategies were collected and reviewed. Patients still need comprehensive treatment for recurrent GBM. Surgery may be useful as adjuvant treatment for patients with symptoms due to the effect of the mass or for patients requiring definitive histopathology, but it generally should be combined with another treatment modality; high-precision re-irradiation such as stereotactic radiosurgery or gamma knife is another option. Chemotherapy like fotemustine, or a metronomic schedule of temozolomide regimens and anti-angiogenic agents like bevacizumab could also be considered. Other targeted molecular inhibitors or anti-angiogenic therapies, and immunotherapies are still under investigation and their efficacy needs to be evaluated further in the future. |
| | |
Authors:
|
Juxiang Chen; Tao Xu |
Publication Detail:
|
Type: Journal Article Date: 2013-01-01 |
Journal Detail:
|
Title: Frontiers in bioscience : a journal and virtual library Volume: 18 ISSN: 1093-4715 ISO Abbreviation: Front. Biosci. Publication Date: 2013 |
Date Detail:
|
Created Date: 2013-01-01 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9709506 Medline TA: Front Biosci Country: United States |
Other Details:
|
Languages: eng Pagination: 676-84 Citation Subset: IM |
Affiliation:
|
Department of Neurosurgery, Changzheng Hospital, Second Military Medical University, No. 415 Fengyang Road, Shanghai, China, 200003. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: ROS signaling pathways and biological rhythms: perspectives in crustaceans.
Next Document: Homocysteine induces inflammatory transcriptional signaling in monocytes .